M. Sieber

2.4k total citations
39 papers, 1.3k citations indexed

About

M. Sieber is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, M. Sieber has authored 39 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 15 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in M. Sieber's work include Lymphoma Diagnosis and Treatment (21 papers), Lung Cancer Treatments and Mutations (15 papers) and Silicon and Solar Cell Technologies (7 papers). M. Sieber is often cited by papers focused on Lymphoma Diagnosis and Treatment (21 papers), Lung Cancer Treatments and Mutations (15 papers) and Silicon and Solar Cell Technologies (7 papers). M. Sieber collaborates with scholars based in Germany, Switzerland and Netherlands. M. Sieber's co-authors include Volker Diehl, Andreas Josting, Andreas Engert, B. Lathan, Hans Tesch, P. Koch, Christian Rudolph, Bernd Dörken, MY Mapara and Andreas Engert and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Membrane Science.

In The Last Decade

M. Sieber

38 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Sieber Germany 18 794 603 324 306 202 39 1.3k
Zdeněk Král Czechia 12 327 0.4× 271 0.4× 144 0.4× 181 0.6× 72 0.4× 101 671
Tan Dat Nguyen France 21 211 0.3× 287 0.5× 209 0.6× 355 1.2× 79 0.4× 42 1.3k
Marianne Riepenhausen Germany 13 428 0.5× 155 0.3× 183 0.6× 129 0.4× 283 1.4× 17 759
A. Rashid Dar Canada 25 589 0.7× 1.3k 2.1× 202 0.6× 1.9k 6.1× 115 0.6× 72 3.4k
I.H. Kunkler United Kingdom 19 251 0.3× 412 0.7× 64 0.2× 253 0.8× 64 0.3× 42 1.3k
Yavuz Anacak Türkiye 19 107 0.1× 332 0.6× 206 0.6× 262 0.9× 73 0.4× 57 1.1k
Ruud Wiggenraad Netherlands 25 257 0.3× 717 1.2× 57 0.2× 921 3.0× 66 0.3× 49 2.1k
Lucius F. Sinks United States 21 210 0.3× 467 0.8× 226 0.7× 549 1.8× 353 1.7× 51 1.7k
Jennifer Wright United States 21 137 0.2× 521 0.9× 134 0.4× 573 1.9× 237 1.2× 61 1.9k
Mustafa Kemal Demir Türkiye 17 296 0.4× 59 0.1× 219 0.7× 172 0.6× 56 0.3× 127 1.1k

Countries citing papers authored by M. Sieber

Since Specialization
Citations

This map shows the geographic impact of M. Sieber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Sieber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Sieber more than expected).

Fields of papers citing papers by M. Sieber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Sieber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Sieber. The network helps show where M. Sieber may publish in the future.

Co-authorship network of co-authors of M. Sieber

This figure shows the co-authorship network connecting the top 25 collaborators of M. Sieber. A scholar is included among the top collaborators of M. Sieber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Sieber. M. Sieber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kluska, Sven, et al.. (2022). Enabling savings in silver consumption and poly-Si thickness by integration of plated Ni/Cu/Ag contacts for bifacial TOPCon solar cells. Solar Energy Materials and Solar Cells. 246. 111889–111889. 15 indexed citations
3.
Bay, Niels, Jörg Horzel, M. Sieber, et al.. (2014). Reliable Contact Formation for Industrial Solar Cells by Laser Ablation and Ni/Cu Plating. EU PVSEC. 1272–1276. 14 indexed citations
4.
Glatthaar, Markus, D. Kray, Niels Bay, et al.. (2011). Application of SunsPL for fast laser chemical process development. 86. 2866–2869. 1 indexed citations
5.
Sieber, M., et al.. (2005). Infradiaphragmatic versus supradiaphragmatic Hodgkin lymphoma: a retrospective review of 1114 patients. Leukemia & lymphoma. 46(12). 1715–1720. 11 indexed citations
6.
Josting, Andreas, Christian Rudolph, MY Mapara, et al.. (2004). Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG). Annals of Oncology. 16(1). 116–123. 112 indexed citations
7.
Rueffer, U., et al.. (2003). Spleen involvement in Hodgkin's lymphoma: assessment and risk profile. Annals of Hematology. 82(7). 390–396. 20 indexed citations
8.
Hartmann, Pia, U. Rehwald, Bernd Salzberger, et al.. (2003). BEACOPP therapeutic regimen for patients with Hodgkin’s disease and HIV infection. Annals of Oncology. 14(10). 1562–1569. 64 indexed citations
9.
Rüffer, Jens Ulrich, Hans‐Henning Flechtner, Andreas Josting, et al.. (2003). Fatigue in long-term survivors of Hodgkin‘s lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG). European Journal of Cancer. 39(15). 2179–2186. 97 indexed citations
10.
Jetter, Alexander, Stephan Rietbrock, M. Sieber, et al.. (2002). Population pharmacokinetics of cyclo- phosphamide, doxorubicin and etoposide in 30 patients with BEACOPP chemotherapy. International Journal of Clinical Pharmacology and Therapeutics. 40(12). 586–588. 7 indexed citations
11.
Josting, Andreas, Christian Rudolph, Marcel Reiser, et al.. (2002). Time-intensified dexamethasone/cisplatin/cytarabine:an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin’s disease. Annals of Oncology. 13(10). 1628–1635. 149 indexed citations
12.
Ansén, Sascha, Andreas Engert, Juergen Wolf, et al.. (2001). Deutsche Hodgkin-Lymphom-Studiengruppe (DHSG): 20 Jahre Diagnostik, Therapie und Nachsorge von Patienten mit Morbus Hodgkin. Oncology Research and Treatment. 24(1). 35–48. 67 indexed citations
13.
Rueffer, U., Kai Breuer, Andreas Josting, et al.. (2001). Male gonadal dysfunction in patients with Hodgkin’s disease prior to treatment. Annals of Oncology. 12(9). 1307–1311. 131 indexed citations
14.
Tesch, Hans, M. Sieber, & Volker Diehl. (2001). Treatment of Advanced Stage Hodgkin’s Disease. Oncology. 60(2). 101–109. 14 indexed citations
15.
Rueffer, U., M. Sieber, Andreas Josting, et al.. (1999). Prognostic factors for subdiaphragmatic involvement in clinical stage I–II supradiaphragmatic Hodgkin’s disease: A retrospective analysis of the GHSG. Annals of Oncology. 10(11). 1343–1348. 13 indexed citations
16.
Flechtner, Hans‐Henning, Jens Ulrich Rüffer, M. Henry‐Amar, et al.. (1998). Quality of life assessment in Hodgkin’s disease: A new comprehensive approach. Annals of Oncology. 9. s147–s154. 27 indexed citations
17.
Diehl, Volker, M. Sieber, B. Lathan, et al.. (1997). BEACOPP: An intensified chemotherapy regimen in advanced Hodgkin's disease. Annals of Oncology. 8(2). 143–148. 104 indexed citations
18.
Diehl, Volker, Markus Loeffler, Michael Pfreundschuh, et al.. (1995). Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advanced Hodgkin's disease. Annals of Oncology. 6(9). 901–910. 56 indexed citations
19.
Buddeberg, Claus, C. Roland Wolf, M. Sieber, et al.. (1991). Coping Strategies and Course of Disease of Breast Cancer Patients. Psychotherapy and Psychosomatics. 55(2-4). 151–157. 44 indexed citations
20.
Buddeberg, Claus, et al.. (1990). [The significance of psychosocial factors for the course of breast cancer--results of a prospective follow-up study].. PubMed. 141(5). 429–55. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zdeněk Král Breakdown of academic impact, for papers by Tan Dat Nguyen Breakdown of academic impact, for papers by Marianne Riepenhausen Breakdown of academic impact, for papers by A. Rashid Dar Breakdown of academic impact, for papers by I.H. Kunkler Breakdown of academic impact, for papers by Yavuz Anacak Breakdown of academic impact, for papers by Ruud Wiggenraad Breakdown of academic impact, for papers by Lucius F. Sinks Breakdown of academic impact, for papers by Jennifer Wright Breakdown of academic impact, for papers by Mustafa Kemal Demir
Rankless by CCL
2026